Anticancer startup record

A startup company, NanoMedical Systems Inc, founded by Mauro Ferrari of the University of Texas, and colleagues is set to receive a record-breaking funding haul of $3.5m to help it improve anticancer drugs and other medications using nanotechnology and bring them to market. The Commercialization Award is given through the Texas Emerging Technology Fund (ETF). "From the information I have, this is the largest commercialization award (to private companies in collaboration with a university for product development) awarded from the emerging technology fund to date," says Wayne Roberts, associate vice president for public policy at the UT Health Science Center at Houston.